These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 778843)

  • 21. Investigations on clinico-chemical correlations in uraemic polyneuritis.
    Man NK; Cueuille G; Zingraff J; Drueke T; Jungers P; Sausse A; Billon JP; Funck-Brentano JL
    Proc Eur Dial Transplant Assoc; 1975; 11():214-21. PubMed ID: 1197256
    [No Abstract]   [Full Text] [Related]  

  • 22. The biochemical basis of uremic toxicity.
    Giordano C
    Int J Pediatr Nephrol; 1982 Dec; 3(4):239-50. PubMed ID: 6762356
    [No Abstract]   [Full Text] [Related]  

  • 23. Peripheral metabolism of parathyroid hormone. Studies with isolated perfused kidneys and livers from normal and uremic rats.
    Daugaard H
    Dan Med Bull; 1996 Jun; 43(3):203-15. PubMed ID: 8813452
    [No Abstract]   [Full Text] [Related]  

  • 24. Separation of peptides of "middle" molecular weight from biological fluids of patients with uremia.
    Fürst P; Bergström J; Gordon A; Johnsson E; Zimmerman L
    Kidney Int Suppl; 1975 Feb; (3):272-5. PubMed ID: 1057698
    [No Abstract]   [Full Text] [Related]  

  • 25. [Parathormone as a uremic toxin. Possible effect on respiratory muscle function in uremia].
    Gómez-Fernández P; Sánchez Agudo L; Calatrava JM; Martínez ME; Escuin Sancho F; Selgas R; Sánchez Sicilia L
    Med Clin (Barc); 1984 Mar; 82(9):395-7. PubMed ID: 6717152
    [No Abstract]   [Full Text] [Related]  

  • 26. Parathyroid hormone in kidney failure.
    Contrib Nephrol; 1980; 20():1-156. PubMed ID: 7398330
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium metabolism in patients with chronic uremia.
    Wiecek A
    Clin Nephrol; 1996 Oct; 46(4):277-9. PubMed ID: 8905220
    [No Abstract]   [Full Text] [Related]  

  • 28. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxicity of parathyroid hormone in uremia.
    Massry SG
    Kidney Int Suppl; 1985 Dec; 17():S5-11. PubMed ID: 3912589
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolism of polypeptide hormones by the kidney.
    Ardaillou R; Paillard F
    Adv Nephrol Necker Hosp; 1980; 9():247-69. PubMed ID: 6773315
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of cefazolin, a new cephalosporin antibiotic, in normal and uraemic patients.
    Leroy A; Canonne MA; Fillastre JP; Humbert G
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):878-89. PubMed ID: 4214662
    [No Abstract]   [Full Text] [Related]  

  • 32. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
    Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
    Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnesium and the haemodialysis patient.
    Stewart JH; Neale FC; Blomfield J
    Lancet; 1969 Oct; 2(7624):798-9. PubMed ID: 4186042
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients.
    Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J
    Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Acid-base status and parathyroid hormone in dialysed patients.
    Mioni G; Castellani A; Cecchettin M; Maiorca R; Heynen G; Franchimont P
    Lancet; 1975 Sep; 2(7935):605. PubMed ID: 51428
    [No Abstract]   [Full Text] [Related]  

  • 36. The course of secondary hyperparathyroidism during chronic hemodialysis.
    Ritz E; Franz HE; Jahns E
    Trans Am Soc Artif Intern Organs; 1968; 14():385-8. PubMed ID: 5701561
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin resistance in uraemia. An insulin receptor or an intracellular defect?
    Schmitz O; Hasling C; Hjøllund E; Hansen HE; Posborg Petersen V; Beck-Nielsen H
    Proc Eur Dial Transplant Assoc; 1983; 20():686-91. PubMed ID: 6657689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
    Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H
    Diabetes Res; 1985 Mar; 2(2):57-63. PubMed ID: 4042532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan and its metabolites in patients on continuous ambulatory peritoneal dialysis and following renal transplantation.
    Qureshi AR; Lindholm B; Garcia E; Groth CG; Bergström J
    Nephrol Dial Transplant; 1994; 9(7):791-6. PubMed ID: 7526276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and toxicity of aliphatic amines.
    Simenhoff ML
    Kidney Int Suppl; 1975 Feb; (3):314-7. PubMed ID: 1057706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.